Some Nigerian anti-tuberculosis ethnomedicines: A preliminary efficacy assessment

Journal of Ethnopharmacology

Volumn 155, Issue 1, 2014, Pages 524-532

  Ibekwe, Nneka N ^a,b   Nvau, John B ^a,b   Oladosu, Peters O ^a   Usman, Auwal M ^a   Ibrahim, Kolo ^a   Boshoff, Helena I ^c   Dowd, Cynthia S ^c,e   Orisadipe, Abayomi T ^a,f   Aiyelaagbe, Olapeju ^b   Adesomoju, Akinbo A ^b   Barry, Clifton E ^c   Okogun, Joseph I ^a,b,d  

^a NATIONAL INSTITUTE FOR PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d Pax Herbal Clinic and Research Laboratories   (Nigeria)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

^f Chemistry Division   (Nigeria)

Author keywords

African ethnomedicines; Anti Mycobacterium activity; Cough; M.bovis (BCG); M.tb.

Indexed keywords

ABRUS PRECATORIUS EXTRACT; ANOGEISSUS LEOCARPUS EXTRACT; CASSIA SIBERIANA EXTRACT; COMBRETUM MOLLE EXTRACT; HERBACEOUS AGENT; ISONIAZID; METHANOL; PENTACLETHRA MACROPHYLLA EXTRACT; PLANT EXTRACT; PTEROCARPUS OSUN EXTRACT; SECURIDACA LONGEPEDUNCULATA EXTRACT; TAPINANTHUS SESSIFOLIA EXTRACT; TERMINALIA AVICENNIOIDES EXTRACT; TETRAPLEURA TETRAPTERA EXTRACT; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ADULT; AQUEOUS SOLUTION; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BROTH DILUTION; COUGHING; DRUG EFFICACY; FEMALE; FEVER; HUMAN; MALE; MEDICINAL PLANT; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS; NIGERIA; PHYTOCHEMISTRY; PLANT; TRADITIONAL HEALER; TRADITIONAL MEDICINE; TUBERCULOSIS; AFRICAN MEDICINE; CHEMISTRY; DRUG EFFECTS; ETHNOPHARMACOLOGY; INFORMATION PROCESSING; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST;

MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; DATA COLLECTION; ETHNOPHARMACOLOGY; FEMALE; HUMANS; MALE; MEDICINE, AFRICAN TRADITIONAL; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NIGERIA; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 84905124366     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2014.05.059     Document Type: Article

References (62)

1. I.A. Adeleye, C.C. Onubogu, C.I. Ayolabi, A.O. Isawumi, and M.E. Nshiogu Screening of crude extracts of twelve medicinal plants and wonder-cure concoction used in Nigeria unorthodox medicine for activity against Mycobacterium tuberculosis isolated from tuberculosis patients sputum African Journal of Biotechnology 7 2008 3182 3187
2. E.K. Adesogan, and D.H.R. Taylor Isolation of a steroid hormone from Khaya gradifoliola Chemical Communications 1967 1365
3. 1- tri-O-methyl flagellic acid and its glucoside from Anogeissus leocarpus Bulletin of the Chemical Society of Ethiopia 14 2000 169 174
4. J.M. Agbedahunsi, and A.A. Elujoba Anti-malarial activity of Khaya grandifoliola stembark Pharmaceutical Biology 36 1998 8 12
5. J.M. Agbedahunsi, and A.A. Elujoba Grandifolin from Khaya grandifoliola stem bark Nigerian Journal of Natural Products and Medicine 2 1998 34
6. J.A. Aladesanmi Tetrapleura tetraptera mollusicidal activity and chemical constituents African Journal of Traditional, Complimentary and Alternative Medicine 4 2007 23 36
7. K. Asres, F. Bucar, S. Edelsbrunner, T. Kartnig, G. Höger, and W. Thiel Investigations on antimycobacterial activity of some Ethiopian medicinal plants Phytotherapy Research 15 2001 323 326
8. C.E. Barry III Modern drug development S.H.E. Kaufmann, H. Hahn, Mycobacterial and TB. Issues in Infectious Diseases 2 2003 Karger Basel 137 150
9. H.I. Boshoff, and D.S. Lun Systems biology approaches to understanding mycobacterial survival mechanisms Drug Discovery Today, Disease Mechanisms 7 2010 75 82
10. V.V. Bumah, E.U. Essien, J.M. Agbedahunsi, and O.U. Eka Effect of Khaya grandifoliola on red blood cells and bone mineral content in rats Journal of Ethnopharmacology 102 2005 446 449
11. M.W. Carroll, M. Lee, Y. Cai, C.W. Hallahan, P.A. Shaw, J.H. Min, L.C. Goldfeder, V. Alekseyev, S. Grinkrug, H.S. Kang, S. Hwang, H.M. Park, E. Kang, S.Y. Lee, B. Jin, H.E. Park, S. Min, S.K. Park, D.S. Jeon, L.E. Via, and C.E. Barry 3rd Frequency of adverse reactions to first- and second-line anti-tuberculosis chemotherapy in a Korean cohort International Journal of Tuberculosis Lung Disorder 16 2012 961 969
12. Center for Disease Control Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, 2000-2004 Weekly 55 11 2006 301 305
13. M. Chaabi, S. Benayache, F. Benayache, S. N'Gom, M. Kone, R. Anton, B. Weniger, and A. Lobstein Triterpenes and polyphenols from Anogeissus leocarpus(Combretaceae) Systematics Ecology 36 2008 59 62
14. C.R. Cho, M. Labow, M. Reinhardt, J. van Oostrum, and M.C. Peitsch The application of systems biology to drug discovery Current Opinion in Chemical Biology 10 2006 294 302
15. O. Christopher, K. Slarko, F. Geogie, P. Alexander, M.R. David, I.A. Petre, I. Yoichiro, and R. Ilya Preparative isolation and identification of tryrosinase inhibitors from the seed of Garcinia kola by high-speed counter-current chromatography Journal of Chromatography A 1151 2007 45 50
16. J.D. Connolly, and R. McCrindle Constitution of grandifolilenone, a novel triterpenoid from Khaya gradifoliola Chemical Communications 1967 1193 1194
17. B.R. Copp Antimycobacterial natural products Natural Product Reports 20 2003 535 557
18. B.R. Copp, and N.A. Pearce Natural product growth inhibitors of Mycobacterium tuberculosis Natural Product Reports 24 2007 278 297
19. rd Development of a selective activity-based probe for adenylating enzymes: profiling MbtA involved in siderophore biosynthesis from Mycobacterium tuberculosis ACS Chemical Biology 7 10 2012 1653 1658
20. P. Duquenois, and R. Anton Chemical study of Cassia sieberiana leaves Planta 16 1968 (184-90)
21. C. Dye, S. Scheele, P. Dolin, V. Pathania, and M.C. Raviglione Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country Journal of the American Medical Association 282 1999 677 686
22. C. Dye Global epidemiology of tuberculosis Lancet 367 2006 938 940
23. G.C. Ebi, and S.I. Ofoefule Antimicrobial activity of Pterocarpus Osun stems Fitoterapia 71 2001 433 435
24. G.N. Folefoc, J.P. Bisseck, Z.T. Fomum, and B. Bodo Constituents from the roots of Pentaclethra macrophylla Biochemical Systematics and Ecology 33 2005 1280 1282
25. S.G. Franzblau, M.A. DeGroote, S.H. Cho, K. Andries, E. Nuermberger, I.M. Orme, K. Mdluli, I. Angulo-Barturen, T. Dick, V. Dartois, and A.J. Lenaerts Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis Tuberculosis 92 2012 453 488
26. N.R. Gandhi, P. Nunn, K. Dheda, H.S. Schaaf, M. Zignol, D. Soolingel, P. Jensen, and J. Bayona Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis Lancet 375 2010 1830 1843
27. E. Green, A. Samie, C.L. Obi, P.O. Bessong, and R.N. Ndip Inhibitory properties of selected South African medicinal plants against Mycobacterium tuberculosis Journal of Ethonopharmacology 130 2010 151 157
28. K. Hostettmann, J.-L. Wolfender, S. Rodriguez, and A. Marston Strategy in the search for bioactive plant constituents K. Hostettmann, F. Chinyanganya, M. Maillard, J-L. Wolfender, Chemistry, Biological and Pharmacological Properties of African Medicinal Plants 1996 University of Zimbabwe Harare 21 42
29. J.A. Ibrahim, and A.E. Ayodele Taxonomic revision of Loranthaceae in Nigeria Nigerian Journal of Botany 24 2011 153 188
30. M.M. Iwu, O.A. Igboko, U.A. Onwuchekwa, and C.O. Okunji Evaluation of the antihepatoxic activity of the bioflavanoids of Garcinia kola seeds Journal of Ethnopharmacology 21 1987 127 138
31. M.M. Iwu, O.A. Igboko, C.O. Okunji, and M.S. Tempesta Antidiabetic and aldose reductase activities of biflavanones of Garcinia kola Journal of Pharmacy and Pharmacology 42 1990 290 292
32. M.M. Iwu Introduction: therapeutic agents from ethnomedicine M.M Iwu, J.C. Wootton, Ethnomedicine and Drug Discovery 2002 Elsevier Science B.V. Amsterdam, The Netherlands 1 22
33. J. Khazir, B.A. Mir, S.A. Mir, and D. Cowan Natural products as lead compounds in drug discovery Journal of Asian Natural Products Research 15 2013 764 788
34. L. Lall, and J.J.M. Meyer in vitro inhibition of drug-resistant and drug-sensitive strain of Mycobacterium tuberculosis by ethnobotanically selected South Africa plants Journal of Ethnopharmacology 66 1999 347 354
35. A.M. Lannang, D. Lontsi, F.N. Ngounou, B.L. Sondengan, A.E. Nkengfack, F.R. Van-Heeerden, and J.C.N. Assob Securidacaxanthone A, a heptaoxygenated xanthone from Securidaca longepedunculata Fitoterapia 77 2006 199 202
36. C. Limmatvapirat, S. Sirisopanaporn, and P. Kittakoop Antitubercular and antiplasmodial constituents of Abrus precatorius Planta Medica 70 2004 276 278
37. A. Mann, J.O. Amupitan, A.O. Oyewale, J.I. Okogun, K. Ibrahim, P. Oladosu, L. Lawson, I. Olajide, and A. Nnamdi Evaluation of in vitro antimycobacterial activity of Nigerian plants used for treatment of respiratory diseases African Journal of Biotechnology 7 2008 1630 1636
38. A. Mann, J.O. Amupitan, A.O. Oyewale, J.I. Okogun, and K. Ibrahim Chemistry of secondary metabolites and their antimicrobial activity in the drug development process: a review of the genus Anogeissus Medicinal Plants 1 2009 1 23
39. A. Mann, K. Ibrahim, A.O. Oyewole, J.O. Amupitan, and J.I. Okogun Antimycobacterial activity of some medicinal plants in Niger State, Nigeria African Journal Infectious Diseases 3 2009 44 48
40. A. Mann, K. Ibrahim, A.O. Oyewale, J.O. Amupitan, M.O. Fatope, and J.I. Okogun Antimycobacterial Friedelane-terpenoid from the Root Bark of Terminalia avicennioides American Journal of Chemistry 1 2 2011 52 55
41. C. Mitnick, J. Bayona, E. Palacious, S. Shin, J. Furin, F. Alcantara, E. Sanchez, M. Sarria, M. Becerra, M.C.S. Fawzi, S. Kapiga, D. Neuberg, J.H. Maguire, J.Y. Kim, and P. Farmer Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru New England Journal of Medicine 348 2003 119 128
42. L.A. Mitscher, and W.R. Baker Tuberculosis: a search for novel therapy starting with natural products Medicinal Research Reviews 18 1998 363 374
43. nd ed. 1988 Springer-Verlag New York 13 22
44. K.C. Ndukwe, A. Lamikanra, and I.N. Okeke Antibacterial in plants used as chewing sticks in Africa Drugs of the future 29 2004 1221
45. D.J. Newman, G.M. Cragg, and K.M. Snader Natural products as sources of new drugs over the period 1981-2002 Journal of Natural Products 66 2005 1022 1037
46. D.J. Newman, and G.M. Cragg Natural products as sources of new drugs over the last 25 years Journal of Natural Products 70 2007 461 477
47. st Century natural products research and drug development and traditional medicine Natural Products Reports 30 2013 584 592
48. A.L. Okunade, M.P.F. Elvin-Lewis, and W.H. Lewis Natural antimycobacterial metabolites: current status Phytochemistry 65 2004 1017 1032
49. T. Oluronke, X. Hoxg-Xi, and F.L. Song Antibacterial activities of extracts from Nigeria chewing stick Phytotherapy Research 13 1999 675 679
50. R.R. Paris, and S. Etchepare Cassia sieberiana polyphenols: isolation of 1-epicatechol and leucopelargonidol Annales Pharmaceutiques Francaides 25 1967 343 346
51. E.F. Queiroz, J.-L. Wolfender, and K. Hostettmann Modern approaches in the search for new lead antiparasitic compounds from higher plants Current Drug Targets 10 2009 202 211
52. C.B. Rogers, and I. Thevan Identification of mollic acid a-l-arabinose, hydroxycycloartenoid from C. molle leaves Phytochemistry 25 1996 1759 1761
53. L-F. Shyur, and N-S. Yang Metabolomics for phytomedicine research and drug development Current Opinion in Chemical Biology 12 2008 66 71
54. P.G. Smith, and A.R. Moss Epidemiology of Tuberculosis B.R. Bloom, Pathogenesis, Protection and Control 1994 American Chemical Society for Microbiology Press 47 59
55. J.C. Sundarmurthi, S. Brindha, T.B.K. Reddy, and L.E. Hanna Informatics resources for tuberculosis: towards drug discovery Tuberculosis 92 2012 133 138
56. Y.T. Tang, and G.R. Marshall Virtual screening for lead discovery Methods in Molecular Biology 716 2011 1 22
57. The Economist, 1995. TB: Join the DOTS. May 20. p.89.
58. K. Waffo, G.A. Azebaze, A.E. Nkengfac, Z.T. Fomum, M. Meyer, B. Bodo, and F.R. van Heerden Indicannines B and C, two isoflavonoid derivatives from the root bark of Erythrina indica Phytochemistry 53 2000 981 985
59. T.N.C. Wells Natural products as starting points for future anti-malarial therapies: going back to our roots? Malaria Journal 10 Suppl. 1 2011 1 12
60. C.C. Whalen Failure of directly observed treatment for tuberculosis in Africa: a call for new approaches Clinical Infectious Diseases 42 2006 1048 1050
61. J.-L. Wolfender HPLC in natural product analysis: the detection issue Planta Medica 75 2009 719 734
62. World Health Organisation. 2008. Global tuberculosis - control surveillance, planning and financing. WHO Report WHO/HTM/Tb/2008.393.